Clinicopathologic characteristics of patients with nonsmall cell lung carcinoma with elevated serum progastrin‐releasing peptide levels
BACKGROUND Progastrin‐releasing peptide (proGRP) is a specific tumor marker in patients with small cell lung carcinoma (SCLC). It has been reported that serum proGRP levels rarely are elevated in patients with nonsmall cell lung carcinoma (NSCLC); the reported frequency is
Gespeichert in:
Veröffentlicht in: | Cancer 1998-03, Vol.82 (6), p.1056-1061 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | BACKGROUND
Progastrin‐releasing peptide (proGRP) is a specific tumor marker in patients with small cell lung carcinoma (SCLC). It has been reported that serum proGRP levels rarely are elevated in patients with nonsmall cell lung carcinoma (NSCLC); the reported frequency is |
---|---|
ISSN: | 0008-543X 1097-0142 |
DOI: | 10.1002/(SICI)1097-0142(19980315)82:6<1056::AID-CNCR7>3.0.CO;2-C |